Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Witzke

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Transplantation|October 3, 2000
Intragraft interleukin-4 mRNA expression after short-term CD154 blockade may trigger delayed development of transplant arteriosclerosis in the absence of CD8+ T cellsS M Ensminger, B M Spriewald, O Witzke, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 24, 1998
Sequential changes of biochemical bone parameters after kidney transplantationW Reinhardt, H Bartelworth, F Jockenhövel, et al.
BMC Pulmonary Medicine|December 6, 2017
The lung microbiome in patients with pneumocystosisJ Kehrmann, B Veckollari, D Schmidt, et al.
Clinical and Experimental Immunology|April 5, 2012
Cyclosporin but not everolimus inhibits chemokine receptor expression on CD4+ T cell subsets circulating in the peripheral blood of renal transplant recipientsA Hoerning, S Köhler, C Jun, et al.
Studies in Health Technology and Informatics|April 25, 2001
Using immersive VR as a tool for preoperative planning for minimally invasive donor nephrectomyM J Mastrangelo, J D Hoskins, M Nicholls, et al.
Clinical Nephrology|May 26, 2010
The German registry for nephrogenic systemic fibrosis: findings from 23 patientsS Becker, S Walter, O Witzke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2001
Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulationS M Ensminger, B M Spriewald, H V Sorensen, et al.
Infection|March 10, 2025
Antibiotic resistance of urinary pathogens after kidney transplantation: a 10-year single-center survey in GermanyP Weber, P Braß, J Jäger, et al.
Scandinavian Journal of Immunology|June 8, 2012
Peripherally circulating CD4⁺ FOXP3⁺ CXCR3⁺ T regulatory cells correlate with renal allograft functionA Hoerning, S Köhler, C Jun, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 19, 2014
Five-year outcomes in kidney transplant patients converted from cyclosporine to everolimus: the randomized ZEUS studyK Budde, F Lehner, C Sommerer, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Transplantation|October 3, 2000
Intragraft interleukin-4 mRNA expression after short-term CD154 blockade may trigger delayed development of transplant arteriosclerosis in the absence of CD8+ T cellsS M Ensminger, B M Spriewald, O Witzke, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 24, 1998
Sequential changes of biochemical bone parameters after kidney transplantationW Reinhardt, H Bartelworth, F Jockenhövel, et al.
BMC Pulmonary Medicine|December 6, 2017
The lung microbiome in patients with pneumocystosisJ Kehrmann, B Veckollari, D Schmidt, et al.
Clinical and Experimental Immunology|April 5, 2012
Cyclosporin but not everolimus inhibits chemokine receptor expression on CD4+ T cell subsets circulating in the peripheral blood of renal transplant recipientsA Hoerning, S Köhler, C Jun, et al.
Studies in Health Technology and Informatics|April 25, 2001
Using immersive VR as a tool for preoperative planning for minimally invasive donor nephrectomyM J Mastrangelo, J D Hoskins, M Nicholls, et al.
Clinical Nephrology|May 26, 2010
The German registry for nephrogenic systemic fibrosis: findings from 23 patientsS Becker, S Walter, O Witzke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2001
Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulationS M Ensminger, B M Spriewald, H V Sorensen, et al.
Infection|March 10, 2025
Antibiotic resistance of urinary pathogens after kidney transplantation: a 10-year single-center survey in GermanyP Weber, P Braß, J Jäger, et al.
Scandinavian Journal of Immunology|June 8, 2012
Peripherally circulating CD4⁺ FOXP3⁺ CXCR3⁺ T regulatory cells correlate with renal allograft functionA Hoerning, S Köhler, C Jun, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 19, 2014
Five-year outcomes in kidney transplant patients converted from cyclosporine to everolimus: the randomized ZEUS studyK Budde, F Lehner, C Sommerer, et al.
Pageof 9